First approved for use in Canada in July 2015, Mifegymiso is a two-drug combination for terminating pregnancy in the first nine weeks. Without health insurance, the cost of the treatment is between $300 and $450. On April 4, 2017, New Brunswick became the first province in Canada to announce that the treatment would be made available to residents without cost.